GURUFOCUS.COM » STOCK LIST » Real Estate » REITs » BioMed Realty Trust Inc (NYSE:BMR) » Definitions » Gross Margin %

BioMed Realty Trust (BioMed Realty Trust) Gross Margin % : 64.40% (As of Sep. 2015)


View and export this data going back to . Start your Free Trial

What is BioMed Realty Trust Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. BioMed Realty Trust's Gross Profit for the three months ended in Sep. 2015 was $112.3 Mil. BioMed Realty Trust's Revenue for the three months ended in Sep. 2015 was $174.3 Mil. Therefore, BioMed Realty Trust's Gross Margin % for the quarter that ended in Sep. 2015 was 64.40%.


The historical rank and industry rank for BioMed Realty Trust's Gross Margin % or its related term are showing as below:


BMR's Gross Margin % is not ranked *
in the REITs industry.
Industry Median: 68.8
* Ranked among companies with meaningful Gross Margin % only.

BioMed Realty Trust had a gross margin of 64.40% for the quarter that ended in Sep. 2015 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for BioMed Realty Trust was 0.00% per year.


BioMed Realty Trust Gross Margin % Historical Data

The historical data trend for BioMed Realty Trust's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioMed Realty Trust Gross Margin % Chart

BioMed Realty Trust Annual Data
Trend Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 70.90 70.71 70.62 71.12 68.20

BioMed Realty Trust Quarterly Data
Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 67.50 67.74 67.05 65.01 64.40

Competitive Comparison of BioMed Realty Trust's Gross Margin %

For the REIT - Office subindustry, BioMed Realty Trust's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioMed Realty Trust's Gross Margin % Distribution in the REITs Industry

For the REITs industry and Real Estate sector, BioMed Realty Trust's Gross Margin % distribution charts can be found below:

* The bar in red indicates where BioMed Realty Trust's Gross Margin % falls into.



BioMed Realty Trust Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

BioMed Realty Trust's Gross Margin for the fiscal year that ended in Dec. 2014 is calculated as

Gross Margin % (A: Dec. 2014 )=Gross Profit (A: Dec. 2014 ) / Revenue (A: Dec. 2014 )
=460.1 / 674.609
=(Revenue - Cost of Goods Sold) / Revenue
=(674.609 - 214.502) / 674.609
=68.20 %

BioMed Realty Trust's Gross Margin for the quarter that ended in Sep. 2015 is calculated as


Gross Margin % (Q: Sep. 2015 )=Gross Profit (Q: Sep. 2015 ) / Revenue (Q: Sep. 2015 )
=112.3 / 174.348
=(Revenue - Cost of Goods Sold) / Revenue
=(174.348 - 62.069) / 174.348
=64.40 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


BioMed Realty Trust  (NYSE:BMR) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

BioMed Realty Trust had a gross margin of 64.40% for the quarter that ended in Sep. 2015 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


BioMed Realty Trust Gross Margin % Related Terms

Thank you for viewing the detailed overview of BioMed Realty Trust's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


BioMed Realty Trust (BioMed Realty Trust) Business Description

Traded in Other Exchanges
N/A
Address
BioMed Realty Trust Inc, a Maryland corporation was formed on April 30, 2004 and commenced operations on August 11, 2004, after completing its initial public offering. The Company operates as a self-administered and self-managed real estate investment trust focused on acquiring, developing, owning, leasing and managing laboratory and office space for the life science industry mainly through its subsidiary, BioMed Realty, L.P., a Maryland limited partnership Its tenants mainly include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. The Company's properties are generally located in markets with well established reputations as centers for scientific research, including Boston, San Diego, San Francisco, Seattle, Maryland, Pennsylvania and New York/ New Jersey. The Company faces competition from various entities for investment opportunities in properties for life science tenants, including other REITs, such as health care REITs and suburban office property REITs, pension funds, insurance companies, investment funds and companies, partnerships, and developers. The Company's properties are subject to various laws, ordinances and regulations, including regulations relating to common areas.
Executives
Daniel Bradbury director BIOBRIT, LLC, 2223 AVENIDA DE LA PLAYA, SUITE 108, LA JOLLA CA 92037
Brody William R Md Phd director MEDTRONIC, INC, 710 MEDTRONIC PKWY, MS LC310, MINNEAPOLIS MN 55432-5604
Janice L. Sears director 1100 PARK PLACE, SUITE 200, SAN MATEO CA 94403
Alan D Gold director, officer: Chairman, President and CEO 17140 BERNARDO CENTER DRIVE, SUITE 195, SAN DIEGO CA 92128
Gary A Kreitzer director, officer: Exec VP and Assistant Sec 17140 BERNARDO CENTER DRIVE, SUITE 195, SAN DIEGO CA 92128
Margaret Faye Wilson director 12836 LUNADA PLACE, SAN DIEGO CA 92128
Griffin R Kent Jr officer: President and COO 5950 SHERRY LANE, SUITE 700, DALLAS TX 75225
Richard I Gilchrist director 5950 SHERRY LANE, SUITE 700, DALLAS TX 75225